Good genes gone bad: (Record no. 4661)

MARC details
000 -LEADER
fixed length control field 01779nam a22001937a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230127163010.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230127b ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780670096039
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.309
Item number CHI
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Chirmule, Narendra
245 ## - TITLE STATEMENT
Title Good genes gone bad:
Remainder of title a short history of vaccines and biologics
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Name of publisher, distributor, etc. Penguin Random House India Pvt. Ltd.
Place of publication, distribution, etc. Haryana
Date of publication, distribution, etc. 2021
300 ## - PHYSICAL DESCRIPTION
Extent xxxvi, 202 p.
365 ## - TRADE PRICE
Price type code INR
Price amount 599.00
520 ## - SUMMARY, ETC.
Summary, etc. The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures.<br/>Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon’s approval of the first biologic drug for breast cancer.<br/>Written by the former R&D head of Biocon, India’s largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biologicals
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs--Research
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Bill No Bill Date Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Accession Number Date last seen Copy number Cost, replacement price Price effective from Koha item type
    Dewey Decimal Classification     Non-fiction IN30543 11-01-2023 Indian Institute of Management LRC Indian Institute of Management LRC General Stacks 01/27/2023 Overseas Press India Private 411.21   615.309 CHI 004400 01/27/2023 1 599.00 01/27/2023 Book

©2019-2020 Learning Resource Centre, Indian Institute of Management Bodhgaya

Powered by Koha